Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Evaluation of Ampicillin/Sulbactam in Patients with Ventilator Associated Pneumonia
IRCT20180802040665N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ampicillin + sulbactam in ventilator-associated pneumonia (VAP), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2024; status: completed.
02
Drugs
ampicillin + sulbactam
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20180802040665N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180802040665N2.